CHRISTIANE J FERRAN, M.D.
Osteopathic Medicine at Brookline Ave, Boston, MA
License number
Massachusetts 158965
Category
Osteopathic Medicine
Type
Nephrology
Address
Address
2
99 Brookline Ave, Boston, MA 02215
23 Naples Rd, Brookline, MA 02446
23 Naples Rd, Brookline, MA 02446
Phone
(617) 632-0840
Personal information
See more information about CHRISTIANE J FERRAN at radaris.comName
Address
Phone
Brookline, MA
165 Winchester St, Brookline, MA 02446
23 Naples, Brockton, MA 02301
92 Landseer St, West Roxbury, MA 02132
23 Naples Rd, Brookline, MA 02446
Professional information
Professor At Bidmc, Harvard Medical School
Position:
Professor at BIDMC, Harvard Medical SChool
Location:
Greater Boston Area
Industry:
Research
Work:
BIDMC, Harvard Medical SChool
since 2009
-
Professor
Dr. Christiane J Ferran - MD (Doctor of Medicine)
Hospitals:
99 Brookline Ave, Boston 02215
99 Brookline Ave, Boston 02215
99 Brookline Ave, Boston 02215
Christiane J Ferran, Boston MA
Specialties:
Nephrologist
Address:
99 Brookline Ave, Boston, MA 02215
Use Of Pro-Apoptotic Factors In Treatment Of Atherosclerosis
US Patent:
7297685, Nov 20, 2007
Filed:
Jun 13, 2003
Appl. No.:
10/461200
Inventors:
Christiane Ferran - West Roxbury MA, US
Maria B. Arvelo - Quincy MA, US
Maria B. Arvelo - Quincy MA, US
Assignee:
Beth Israel Deaconess Medical Center - Boston MA
International Classification:
A61N 31/70, A61K 48/00
US Classification:
514 44, 424 932
Abstract:
The present invention features a novel method of treating vascular disease that involves modifying smooth muscle cells to express a gene encoding a protein having both anti-inflammatory and pro-apoptotic activity. Preferably, the protein of the invention also has an anti-proliferative effect in smooth muscle cells. In general, the method is useful in preparing vascularized organs and vessels for transplant into a patient. Alternatively, the present invention can be applied to treat atherosclerotic lesions in damaged vessels.
Use Of Pro-Apoptotic Factors In Treatment Of Atherosclerosis
US Patent:
2001005, Dec 20, 2001
Filed:
Jan 19, 2001
Appl. No.:
09/765519
Inventors:
Christiane Ferran - West Roxbury MA, US
Maria Arvelo - Quincy MA, US
Maria Arvelo - Quincy MA, US
International Classification:
A61K048/00, C12N005/06
US Classification:
514/044000, 424/093210, 435/325000
Abstract:
The present invention features a novel method of treating vascular disease that involves modifying smooth muscle cells to express a gene encoding a protein having both anti-inflammatory and pro-apoptotic activity. Preferably, the protein of the invention also has an anti-proliferative effect in smooth muscle cells. In general, the method is useful in preparing vascularized organs and vessels for transplant into a patient. Alternatively, the present invention can be applied to treat atherosclerotic lesions in damaged vessels.
Measurement Of Protective Genes In Allograft Rejection
US Patent:
2002013, Sep 19, 2002
Filed:
Feb 6, 2001
Appl. No.:
09/777732
Inventors:
Nalli Ma - Wirchester MA, US
Terry Strom - Brookline MA, US
Miguel Soares - Boston MA, US
Christiane Ferran - Brookline MA, US
Manikkam Suthanthiran - Scarsdale NY, US
Terry Strom - Brookline MA, US
Miguel Soares - Boston MA, US
Christiane Ferran - Brookline MA, US
Manikkam Suthanthiran - Scarsdale NY, US
International Classification:
C12Q001/68
US Classification:
435/006000
Abstract:
The invention relates to methods of evaluating transplant rejection in a host comprising determining a heightened magnitude of gene expression of genes in rejection-associated gene clusters. The disclosed gene clusters include genes that are substantially co-expressed with cytotoxic lymphocyte pro-apoptotic genes, cytoprotective genes and several other cytokine and immune cell genes.